Syschem (India) (BSE 531173)₹32.32+2.25%Pharmaceuticals
In the Jun 2026 quarter (standalone), Syschem (India) reported sales of ₹109 Cr, down 0.2% from Jun 2025, and net profit of −₹1.68 Cr, down 200.0% year on year. For the year to Mar 2026, sales were ₹572 Cr and net profit ₹11.05 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37.00 | 43.62 | 74.49 | 87.25 | 47.34 | 77.50 | 118 | 109 | 103 | 141 | 219 | 109 |
| Expenses | 35.23 | 42.61 | 73.07 | 86.57 | 47.39 | 76.50 | 117 | 107 | 100 | 136 | 210 | 109 |
| Operating Profit | 1.86 | 1.09 | 1.63 | 0.82 | 0.08 | 1.21 | 1.91 | 2.47 | 3.31 | 5.97 | 9.39 | 0.55 |
| OPM % | 5.0% | 2.5% | 2.2% | 0.9% | 0.2% | 1.5% | 1.6% | 2.2% | 3.2% | 4.2% | 4.3% | 0.5% |
| Other Income | 0.00 | 0.00 | 0.14 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| Interest | 0.04 | 0.12 | 0.02 | 0.00 | 0.04 | 0.05 | 0.00 | 0.05 | 0.02 | 0.18 | 2.05 | 0.50 |
| Depreciation | 0.71 | 0.75 | 0.68 | 0.69 | 0.67 | 0.69 | 0.90 | 0.77 | 0.75 | 0.83 | 1.74 | 1.55 |
| Profit before tax | 1.11 | 0.23 | 1.08 | 0.13 | −0.63 | 0.49 | 1.00 | 1.66 | 2.53 | 4.96 | 5.59 | −1.45 |
| Tax % | 0.0% | 0.0% | 123.9% | 0.0% | 0.0% | 0.0% | 54.6% | 0.0% | 25.7% | 16.0% | 69.0% | 15.1% |
| Net Profit | 1.13 | 0.24 | −0.27 | 0.15 | −0.65 | 0.51 | 0.47 | 1.68 | 1.91 | 4.19 | 1.75 | −1.68 |
| EPS (Rs) | 0.29 | 0.07 | −0.08 | 0.05 | −0.17 | 0.14 | 0.12 | 0.39 | 0.45 | 0.97 | 0.37 | −0.35 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.99 | 12.95 | 66.75 | 92.63 | 76.68 | 67.74 | 58.80 | 114 | 198 | 331 | 572 | 572 |
| Expenses | 4.99 | 11.99 | 62.89 | 88.85 | 76.91 | 72.90 | 57.94 | 105 | 192 | 328 | 553 | 554 |
| Operating Profit | −1.01 | 0.00 | 3.01 | 4.01 | 0.00 | −5.01 | 1.01 | 9.01 | 7.01 | 4.01 | 21.03 | 19.22 |
| OPM % | −24.1% | 0.4% | 4.5% | 4.4% | −0.1% | −7.0% | 0.9% | 8.0% | 3.5% | 1.2% | 3.7% | 3.4% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.01 | 2.75 |
| Depreciation | 1.99 | 1.99 | 2.01 | 1.99 | 1.99 | 1.99 | 3.01 | 2.99 | 3.01 | 2.99 | 4.01 | 4.87 |
| Profit before tax | −2.99 | −1.99 | 0.99 | 1.99 | −1.99 | −6.99 | −1.99 | 5.99 | 3.99 | 0.99 | 14.97 | 11.63 |
| Tax % | −26.9% | −29.9% | 43.1% | 50.1% | −15.9% | −23.9% | −21.9% | 27.1% | 33.1% | 54.1% | 26.1% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −2.01 | −1.01 | 0.00 | 1.01 | −2.01 | −6.03 | −2.01 | 5.02 | 3.01 | 0.00 | 11.05 | 6.17 |
| EPS (Rs) | −1.14 | −0.76 | 0.18 | 0.33 | −0.80 | −2.08 | −0.60 | 1.14 | 0.70 | 0.12 | 2.24 | 1.44 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16.01 | 16.01 | 16.02 | 16.04 | 19.04 | 19.04 | 22.05 | 23.05 | 32.09 | 40.10 | 44.09 | 49.11 |
| Reserves | −5.99 | −7.99 | −9.99 | −7.98 | −7.97 | −9.98 | −14.96 | −15.97 | −9.98 | 16.96 | 47.86 | 72.85 |
| Borrowings | 27.97 | 26.96 | 22.00 | 19.99 | 16.01 | 16.99 | 16.01 | 1.99 | 2.01 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 12.94 | 11.94 | 15.92 | 28.87 | 34.85 | 35.89 | 54.87 | 50.82 | 68.77 | 107 | 126 | 169 |
| Total Liabilities | 50.93 | 46.92 | 43.95 | 57.92 | 61.93 | 61.94 | 76.97 | 59.89 | 92.89 | 164 | 217 | 292 |
| Fixed Assets | 33.93 | 31.90 | 29.93 | 28.95 | 26.92 | 27.95 | 29.94 | 31.92 | 30.91 | 30.94 | 52.87 | 67.78 |
| CWIP | 1.01 | 1.01 | 1.01 | 0.00 | 0.00 | 1.01 | 1.01 | 0.00 | 0.00 | 4.01 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 15.99 | 15.01 | 14.01 | 27.97 | 35.01 | 33.98 | 46.02 | 27.97 | 61.98 | 129 | 164 | 224 |
| Inventories | 7.01 | 7.99 | 5.01 | 13.01 | 24.01 | 21.02 | 33.01 | 19.03 | 16.02 | 51.07 | 68.01 | 58.02 |
| Trade receivables | 6.02 | 3.01 | 4.01 | 9.03 | 5.01 | 10.03 | 6.02 | 3.01 | 42.14 | 68.26 | 90.28 | 144 |
| Cash & equivalents | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 1.01 | 0.00 | 2.01 | 9.02 |
| Total Assets | 50.93 | 46.92 | 43.95 | 57.92 | 61.93 | 61.94 | 76.97 | 59.89 | 92.89 | 164 | 217 | 292 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.01 | 0.00 | 6.01 | 0.00 | −2.01 | 3.01 | 4.01 | 1.01 | −8.01 | −26.06 | −10.02 | 8.02 |
| Cash from investing activity | 0.00 | 0.00 | 0.00 | 0.00 | 2.01 | −4.01 | −4.01 | −1.01 | −2.01 | −6.01 | −22.06 | −20.06 |
| Cash from financing activity | −2.01 | −1.01 | −7.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.01 | 32.04 | 34.03 | 18.02 |
| Net cash flow | −0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 1.99 | 5.98 |
| Capex | 0.14 | 0.00 | 0.41 | 1.72 | 1.04 | 3.43 | 5.09 | 3.42 | 1.95 | 6.65 | 21.60 | 18.20 |
| Free cash flow | 0.99 | 0.00 | 5.98 | −0.99 | −1.99 | 0.00 | −0.99 | −1.99 | −9.97 | −31.90 | −31.89 | −10.96 |
| CFO / OP % | −55.9% | −52.9% | 12,760.1% | 9.1% | −23.9% | −3,455.9% | −39.9% | 107.1% | −78.9% | −347.9% | −237.9% | 54.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 187 | 272 | 124 | 47 | 21 | 47 | 31 | 21 | 135 | 126 | 99 | 92 |
| Inventory days | 227 | 867 | 181 | 79 | 103 | 109 | 198 | 151 | 60 | 106 | 80 | 40 |
| Days payable | 291 | 871 | 425 | 152 | 132 | 176 | 222 | 187 | 159 | 199 | 144 | 113 |
| Cash conversion cycle | 124 | 271 | −119 | −24 | −7 | −19 | 9 | −14 | 38 | 34 | 36 | 21 |
| Working capital days | −138 | −563 | −318 | −49 | −19 | −35 | 0 | −14 | 49 | 55 | 40 | 30 |
| ROCE % | −11.0% | −8.0% | −6.0% | 3.0% | 7.0% | −8.0% | −29.0% | −11.9% | 38.1% | 11.0% | 1.0% | 16.0% |
For the Jun 2026 quarter, Syschem (India) reported sales of ₹109 Cr, down 0.2% year on year and net profit of −₹1.68 Cr, down 200.0% year on year. The operating margin was 0.5%.
Syschem (India)'s sales for the year to Mar 2026 were ₹572 Cr; over the last twelve months they were ₹572 Cr.
Net profit for the year to Mar 2026 was ₹11.05 Cr, and ₹6.17 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.44.
Syschem (India) reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹9.02 Cr.
Cash from operations was ₹8.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹10.96 Cr.